Robert D. Anderson is a Principal and focuses on life sciences in the Health Care Investment Banking Group at Piper Jaffray. His transaction experience includes a broad range of merger and acquisition advisories and financings for public and private companies.

Prior to joining Piper Jaffray, he worked in the Health Care investment banking group at RBC Capital Markets (formerly Dain Rauscher Wessels) for more than four years and in operations for RBC Dain Rauscher. Rob earned a Bachelor’s degree in Finance and Economics from the University of St. Thomas.

Mike Blanchette is a partner in the life sciences practice at PRTM Management Consultants, a global management consultancy serving the medical device and other industries. Mike has more than 20 years in operations management and customer support. He has managed a broad range of projects in operations strategy, product development, operations and quality systems. Mike has designed and built field service operations, built and outsourced manufacturing capabilities and driven call center performance improvements. In addition, he has extensive hands-on operations experience, having held numerous management positions in service, operations, process engineering and quality assurance.

Elizabeth Brooks is a mathematician and health economist leveraging ten years of pharmaceutical and medical device experience. She currently serves as Vice President of Health Economics for Reimbursement Principles, Inc. As a medical economics consultant, Beth has a practical approach. She is skilled at identifying clients’ business needs and scaling useful and insightful economic strategies to prove and communicate product value. Beth has designed close to one hundred economic models and developed dozens of overall ‘market development’ plans for her clients.

Her expertise includes: design of cost-effectiveness and budgetary impact models; development of interactive pricing and sales tools; and design, analysis, and communication of prospective health economic studies. Prior to joining Reimbursement Principles, Beth led the health economics group at PPD, Inc., a major contract research organization, and later led PPD’s business development effort for medical communications, health economics and late stage study services.

Beth currently lives in Asheville, NC with her husband, Gary, and her son, Alex. She enjoys the outdoors and spending time with her family. Beth holds a Ph.D. in mathematics from Duke University.

Bill Ellerkamp joined ExtruMed, a catheter centric component manufacturer, in November 2006 as Chief Executive Officer. Bill has over 25 years experience in the medical device industry. Prior to joining ExtruMed Bill was Chief Operating Officer with Ranier Technology Limited, an early stage spinal implant company in the UK.

Before Ranier, Bill was VP, Market Development for MedSource Technologies, a publicly traded $180m medical engineering and manufacturing services provider to the medical device industry, where he was responsible for corporate strategy, business development and marketing .

Prior to joining MedSource in 2000, Bill spent over 18 years with Teleflex Medical, a global diversified medical device manufacturer, in numerous positions in the U.S. and Europe. In his last position with Teleflex Bill was President of Teleflex Medical OEM. Bill holds a BA from Colgate University and a MBA from the London Business School. He is currently on the editorial advisory board of Medical Product Outsourcing, a leading industry publication.

James Douglas is an Associate within the Health Care Group and is involved in a full range of investment banking activities. Prior to joining Piper Jaffray, Douglas worked at Abbott Laboratories in the Corporate Financial Planning and Global Pharmaceutical Operations divisions.

Prior to Abbott he worked at PricewaterhouseCoopers providing audit and transaction services. Jim is a CPA, graduated from the University of Wisconsin – Milwaukee and received a Master of Business Administration degree from the J.L. Kellogg School of Management at Northwestern University.

Doug has more than 20 years of experience in the field of product design. Prior to founding Hiemstra Design in 1991, Doug was a freelance industrial designer working for various manufacturing and consulting firms in the San Francisco Bay Area.

Doug has contributed to more than 175 product development programs for companies including Target Therapeutics (Boston Scientific), Guidant, Ventritex (St. Jude Medical) Boehringer Mannheim (Roche) and Cardio Thoracic Systems (Guidant). Doug holds a Bachelor of Fine Arts degree from University of Kansas, where he majored in Industrial Design.

Joe E. Kiani is the founder of Masimo and has served as Chief Executive Officer and Chairman of the Board of Directors since our inception in 1989. He is an inventor on more than 50 patents related to signal processing, sensors, and patient monitoring, including patents for the invention of measure-through motion and low-perfusion pulse oximetry.

Prior to founding Masimo, Mr. Kiani served as Regional Technical Manager for Anthem Electronics, Inc., a distributor of semiconductor and subsystem products and as Field Applications Engineer for Bell Industries, Inc., which distributes advanced semiconductor components. He also previously served as Product Engineer at Unisys Corporation, a computer manufacturer. Mr. Kiani is currently on the Board of Directors of Saba Software, Inc., a publicly-traded software company focused on human capital development and management solutions and chairman of the Medical Device Manufacturers Association (MDMA). Mr. Kiani holds a B.S.E.E. and an M.S.E.E. from San Diego State University.

Virginia Perry, RAC, CQE, is the founder of and Partner in Perry-D’Amico and Associates, a regulatory and quality management consulting firm, specializing in medical devices. Her over twenty five years of corporate experience in the health care fields includes Nellcor, Inc. as Officer and Vice President RAQA/Clinicals; Baxter Health Care Corporation as Vice President of QARA; American Hospital Supply Corporation as Vice President RAQA; and Warner Lambert.

Her experience includes a variety of products in the drug, large volume parenteral and medical device fields in both domestic and international operations. Mrs. Perry received degrees in Chemistry and Mathematics. She is a Certified Quality Engineer (CQE) and a Certified Regulatory Affairs Professional (RAC). She received the RAPS Leonard J. Stauffer Award – 2001 for outstanding contribution to the regulatory profession. She has served at AdvaMed (former HIMA) as a member of the Advisory Committee to the AdvaMed Board on Product Technology and Regulation, at the Business School Advisory Council for Chapman College in Southern California, as a Regulatory Advisor at the University of California, Santa Cruz and ASQ Chairperson.

She is an active member of the Regulatory Affairs Professional Society (RAPS), and has served as a Director to the RAPS Board, as the RAPS Director for the Pacific Region, and as a member of the Regulatory Affairs Certification Board (RACB).

Nancy Singer is President of Compliance-Alliance, LLC, a firm that specializes in the professional development for those employed in the drug and medical device industries. She began her career as a prosecutor for the United States Department of Justice where she did litigation for the Food and Drug Administration. Subsequently, she was a Partner at the law firm of Kleinfeld, Kaplan and Becker.

During her career, Ms. Singer served as AdvaMed’s Special Counsel for FDA compliance and enforcement matters. In her role as Special Counsel, Ms. Singer was a member of the FDA/industry working group that evaluated and suggested reforms to the FDA inspectional process. She then represented the industry on the working group that conceived and validated the procedures for the Quality System Inspection Technique. She served as the industry spokesperson on the educational programs that taught QSIT to representatives of FDA and the medical device industry. For her efforts, she received Vice President Gore’s Reinventing Government Hammer Award and the FDA Commissioner’s Special Citation Award.

Ms. Singer received her B.S. from Cornell University and her J.D. and LL.M. degrees from New York University Law School. During her career, she taught food and drug law at Catholic University Law School and George Washington University Law School, was chairman of the Food and Drug Law Section of the Federal Bar Association, and is a retired Commander in the United States Navy Reserve.

Mary has an extensive background in the area of Strategic reimbursement for pharmaceuticals, biologics medical devices, and diagnostics.

Currently, Mary is a corporate reimbursement manager at BD. In addition, Mary’s professional experiences relative to strategic reimbursement include being a Principal for Covance Market Access Division and a Director of Reimbursement at Johnson & Johnson. While at J&J Mary held various management positions in reimbursement strategy along with positions in field sales, product marketing, and managed care marketing during which time she worked reimbursement related issues for a variety of drugs, biologics, diagnostics and devices products

Mary has been a feature speaker at Advamed Reimbursement Specialists Program, the Society of Clinical Research national meeting, Regulatory Affairs Professional meetings and a feature speaker for the J&J partnership Lecture Series presenting on the evolving economic and political dynamics in the US healthcare environment.